Amazon.com and UnitedHealth Group have both slid into what analysts now consider undervalued territory, a sign that two of the market’s biggest defensive growth names are offering cheaper entry points after sharp swings in sentiment and price.
Amazon and UnitedHealth turn undervalued
That matters because when large-cap leaders fall below fair-value estimates, it often reflects more than a routine pullback: it can mark a reassessment of earnings durability, margin risk and the market’s willingness to pay up for quality. For investors, the question is not whether these stocks are cheap in isolation, but whether the selloff has created a mispricing in businesses that still sit at the center of consumer spending and U.S. health care.
Amazon’s move is the more striking of the two. The shares closed at $260.43 on Aug. 25, well below the recent peak of $284.02 on Aug. 3, but still above the 50-day moving average of $250.58. The technical picture has cooled from the overbought conditions seen earlier in the month, when the relative strength index briefly climbed to 68.5, yet it remains far from distressed. That combination suggests the stock has come off a momentum high without breaking its longer-term uptrend, a setup that can appeal to value-oriented growth investors if earnings revisions hold up.
UnitedHealth’s valuation reset has been more severe. The insurer ended Aug. 25 at $398.18, down from a July 9 high of $431.68 and still below its 50-day moving average of $413.45. The stock has recovered from a deeper spring selloff, but the recent decline underscores how quickly investors have become less willing to pay premium multiples for managed-care names when there is pressure around costs, reimbursement and earnings visibility. Even so, the shares remain well above the 200-day moving average of $346.07, showing that the longer-term trend has not been fully broken.
The backdrop helps explain why these names are showing up on undervalued screens now. In a market that has rewarded earnings resilience over pure growth at any price, stocks with strong franchises but imperfect near-term visibility have been vulnerable to multiple compression. That is especially true for Amazon, where investors continue to weigh cloud growth, retail margins and heavy investment spending, and for UnitedHealth, where the market is still sensitive to medical-cost trends and regulatory scrutiny across health-care services.
For investors, the opportunity lies in the gap between market price and business quality. Amazon offers operating leverage if retail efficiency holds and cloud demand stabilizes, while UnitedHealth can rerate if medical utilization and pricing dynamics normalize. The bear case is that both stocks deserve a discount: Amazon if capital intensity stays elevated and margins remain uneven, UnitedHealth if health-care cost pressure persists longer than expected.
The broader message from the week’s 4-star additions is that undervaluation is appearing first in companies with scale, cash generation and dominant market positions — not in speculative names. That can be a constructive sign for long-only investors looking for entry points, but it also reflects a market that is becoming more selective about what it is willing to pay for, even among high-quality leaders.
| Entity | Gains | Losses |
|---|---|---|
| Amazon | ▲Value buyers | ▼Momentum traders |
| UnitedHealth | ▲Long-term investors | ▼Premium multiple holders |
| Defensive growth stocks | ▲Selective rerating | ▼Expensive growth names |
| Investors | ▲Cheaper entry points | ▼Near-term certainty |
